Marshall Wace
EPIX

Marshall Wace’s ESSA Pharma EPIX Stock Holding History

Marshall Wace’s Portfolio EPIX Stock Details EPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-181,217
Closed -$324K – 2746
2024
Q4 		$324K Buy
+181,217
New +$577K ﹤0.01% 2214
2022
Q4 		– Sell
-115,122
Closed -$209K – 3060
2022
Q3 		$209K Buy
115,122
+93,729
+438% +$247K ﹤0.01% 3071
2022
Q2 		$67K Buy
+21,393
New +$120K ﹤0.01% 3310
2022
Q1 		– Sell
-9,620
Closed -$137K – 3513
2021
Q4 		$137K Buy
+9,620
New +$107K ﹤0.01% 3296
2021
Q3 		– Sell
-14,479
Closed -$414K – 3121
2021
Q2 		$414K Buy
+14,479
New +$421K ﹤0.01% 2213

Other funds holding EPIX

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
ACM
Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
AC
Aldebaran Capital Carmel, Indiana $133M AUM 42.18% 1-Year Est. Return

Marshall Wace's EPIX Position: Q1 2025 in Review

Marshall Wace sold out of ESSA Pharma (EPIX) in Q1 2025, closing a stake of 181,217 shares — an estimated $324K sold.

Marshall Wace first reported a position in EPIX in Q2 2021 and held it in 5 quarters. The position peaked at $414K in Q2 2021. 36 funds tracked by Wall St. Rank hold EPIX as of Q1 2025.

  • Marshall Wace reported no remaining ESSA Pharma position as of Q1 2025 after selling out during the quarter.
  • Marshall Wace sold 181,217 ESSA Pharma shares in Q1 2025, an estimated $324K.
  • Marshall Wace first reported a position in ESSA Pharma in Q2 2021 and held it in 5 quarters.
  • Marshall Wace's ESSA Pharma position peaked at $414K in Q2 2021.
  • 36 funds tracked by Wall St. Rank held ESSA Pharma as of Q1 2025.

Based on Marshall Wace's 13F filing for Q1 2025, filed 15 May 2025.